BK2011 Diagnostics & Research
- 3955.560
- +22.754+0.58%
Loop Media Selected by RadNet to Provide Ad Sales Services, Branded Channels, and Customized Signage Across RadNetTV
Loop Media, Inc. ("Loop Media") (NYSE:LPTV), a leading multichannel streaming CTV platform that provides curated music videos, sports highlights, news, premium entertainment channels and digital signage for
Express News | Thermo Fisher Scientific Inc : Raymond James Raises Target Price to $650 From $605
Express News | Danaher Corp : Raymond James Raises Target Price to $285 From $270
Revvity Beats Quarterly Estimates on Demand for Diagnostic Equipment
Revvity Q1 Adjusted Earnings, Revenue Down; Lowers 2024 Revenue Guidance
Revvity (RVTY) reported Q1 adjusted earnings Monday of $0.98 per share, down from $1.01 a year earlier. Analysts polled by Capital IQ expected $0.94. Revenue for the quarter ended March 31 was $649.9
Express News | FDA Approves Labcorp's NAbCyte Anti-AAVRh74var HB-FE, Companion Diagnostic To Determine Patient Eligibility For Treatment With Beqvez (Fidanacogene Elaparvovec-dzkt), Pfizer's Recently FDA-Approved Hemophilia B Gene Therapy
Revvity Q1 24 Earnings Conference Call At 8:00 AM ET
Express News | Labcorp Receives FDA Approval for First Companion Diagnostic for Use With Pfizer's Newly Approved Gene Therapy to Treat Patients With Hemophilia B
Express News | Bio-Techne Announces New Distribution Agreement With Thermo Fisher Scientific
Raymond James Adjusts Price Target on Danaher to $285 From $270, Keeps Outperform Rating
Danaher (DHR) has an average outperform rating and a price target range of $208 to $300, according to analysts polled by Capital IQ. Price: 246.23, Change: -0.35, Percent Change: -0.14
Raymond James Adjusts Price Target on Thermo Fisher Scientific to $650 From $605, Keeps Outperform Rating
Thermo Fisher Scientific (TMO) has an average rating of outperform and price targets ranging from $540 to $677, according to analysts polled by Capital IQ. Price: 574.00, Change: +0.40, Percent Change
Express News | Revvity Reaffirms Its 2024 Adjusted EPS Guidance Of $4.55-$4.75 Versus Consensus Of $4.65 And Organic Growth Guidance Of 1-3%
Revvity Earnings Beat by $0.04, Revenue Topped Estimates
Express News | Revvity Revises 2024 Revenue Forecast To $2.76B-$2.82B From Prior Guidance Of $2.79B-$2.85B Versus Consensus Of $2.81B
Revvity Beats Top-line and Bottom-line Estimates; Updates FY24 Outlook
Revvity Raises 2024 Guidance>RVTY
Revvity Raises 2024 Guidance>RVTY
Earnings Flash (RVTY) REVVITY Reports Q1 Revenue $649.9M, Vs. Street Est of $647.5M
06:01 AM EDT, 04/29/2024 (MT Newswires) -- Earnings Flash (RVTY) REVVITY Reports Q1 Revenue $649.9M, vs. Street Est of $647.5M
Express News | Revvity Outlook FY Revenue USD 2,760-2,820 Million
Express News | Revvity Inc FY2024 Shr View $4.65, Rev View $2.82 Bln -- Lseg Ibes Data
Express News | Revvity Inc: Updating Its Full Year 2024 Total Revenue Guidance to a Range of $2.76-$2.82 Bln